SMURF2 and nonpapillary renal cell carcinoma: Interestingly, and as mentioned above, the observation that increased levels of SMURF2 exhibit a favorable association with improved survival in clear cell renal cell carcinoma (ccRCC), thereby emphasizing its potential value as a biomarker (12, 13).